Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,536 | 1,786 | 1,046 | 1,059 | -439 |
| Depreciation Amortization | 4,181 | 2,779 | 1,366 | 4,792 | 3,679 |
| Accounts receivable | -94 | -494 | 2,226 | -1,506 | -520 |
| Other Working Capital | -4,563 | -3,483 | -2,186 | -153 | -421 |
| Other Operating Activity | 847 | 915 | -2,020 | 4,327 | 2,720 |
| Operating Cash Flow | $2,907 | $1,504 | $432 | $8,520 | $5,020 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,941 | -7,033 | -2,290 | -4,489 | -5,414 |
| PPE Investments | -1,398 | -950 | -427 | -2,091 | -1,410 |
| Purchase Sale Intangibles | -88 | -66 | -46 | -2,211 | -2,106 |
| Other Investing Activity | -61 | -21 | -67 | -1,911 | -1,780 |
| Investing Cash Flow | $-9,400 | $-8,005 | $-2,784 | $-8,490 | $-8,604 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1,056 | -1,076 |
| Common Stock Issued | 5,666 | 5,434 | 295 | 711 | 368 |
| Common Stock Repurchased | N/A | N/A | N/A | -289 | -289 |
| Financing Cash Flow | $5,666 | $5,434 | $295 | $-634 | $-997 |
| Exchange Rate Effect | 10 | 4 | -41 | 141 | -490 |
| Beginning Cash Position | 7,846 | 7,846 | 7,846 | 8,309 | 8,309 |
| End Cash Position | 7,029 | 6,783 | 5,748 | 7,846 | 3,238 |
| Net Cash Flow | $-817 | $-1,063 | $-2,099 | $-463 | $-5,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,907 | 1,504 | 432 | 8,520 | 5,020 |
| Capital Expenditure | -1,398 | -950 | -427 | -2,091 | -1,410 |
| Free Cash Flow | 1,509 | 553 | 5 | 6,429 | 3,610 |